In the present study, our dosage of C21 was chosen based on the murine study of Schwengel et al.25, wherein the effect of post-stroke C21 treatment after MCAO was assessed in AT2−/y and AT2+/y mice. The gene discussed is AGTR2; the disease is Stroke.